Celgene files patent suit against KV Pharmaceuticals over generic version of Focalin XR®
October 2009
Jones Day represents Celgene Corporation in a Hatch-Waxman patent infringement action concerning ADHD drug product Focalin XR®.
Celgene Corporation, et al. v. KV Pharmaceutical Company (D. N.J.)
For additional information about this matter, please contact: Lester J. Savit, Anthony M. Insogna
Client(s): Celgene Corporation